FY26 bone marrow failure research program (bmfrp) support

Active Awarded Last action

Contract number
HT942726FE042
Awardee
Awarding agency
Obligated
$155,357

Award facts

Contract value 54% obligated
$289,136.20 Current and potential, with all options
Completion date 48% complete
Current and potential, with all options
Contracting staff
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
R408 Support- Professional: Program Management/Support
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21703, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a delivery order to Leidos, Inc. on April 30, 2026, with a ceiling value of $289,136.20 for FY26 Bone Marrow Failure Research Program (BMFRP) support, with completion scheduled for April 29, 2027.

The order is priced cost-plus-fixed-fee. Place of performance is Frederick, Maryland. Leidos, a large prime contractor, competes full-and-open across defense, intelligence, civilian, and health sectors and does not hold SBA small business certifications.

Quick answers

Who was awarded contract HT942726FE042?

HT942726FE042 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on April 30, 2026.

How much is contract HT942726FE042 worth?

The government has obligated $155,357 on HT942726FE042. Its current value, with exercised options, is $289,136.

Is contract HT942726FE042 an order under another contract?

Yes. HT942726FE042 is a delivery order under HT942523D0002, an indefinite delivery contract.

Was contract HT942726FE042 competed?

The extent of competition for HT942726FE042 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award